Hormonal Therapy for Transgender Patients — MCQs

Hormonal Therapy for Transgender Patients — MCQs

Hormonal Therapy for Transgender Patients — MCQs
10 questions
Read Study Notes
Q1

Which of the following is an absolute contraindication to systemic menopausal hormone therapy?

Q2

Which condition is an absolute contraindication to systemic menopausal hormone therapy?

Q3

All of the following are true about the adrenal gland EXCEPT:

Q4

A 32-year-old transgender woman taking oral estradiol and spironolactone has a previous deep-vein thrombosis and is scheduled for vaginoplasty with prolonged postoperative immobilisation. Which preoperative hormonal change is appropriate?

Q5

A 58-year-old postmenopausal woman has vulvar dryness and itching for 3 months. Examination shows diffuse vulvovaginal epithelial thinning without white plaques or scarring. Which treatment corrects the underlying atrophy?

Q6

In Stein-Leventhal syndrome, which hormone is raised?

Q7

A postmenopausal woman has a first episode of uterine bleeding and no major risk factors for endometrial carcinoma. Which initial investigation assesses endometrial thickness?

Q8

In a woman with a regular 28-day menstrual cycle, which hormonal profile is typical on day 21?

Q9

What is the definitive surgical treatment for diffuse adenomyosis?

Q10

Apart from predicting endocrine therapy response, what is the established clinical role of ER positivity in breast carcinoma?

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free
75% OFFLimited time offer
GET 75% OFF